United States Biotechnology & Medical Research

ContraFect Corp (CFRX)

Track

Ticker: CFRX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 13 Dec 2019
Value US$2,328,152.36 | Price 452.11 | Shares 93,540 (-40.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-12-16 2019-12-13 B Purchase Sucoff Cary Non-Executive Director
93,540 -40.0%
452.11
US$2,328,152 		93,540 -40.0% 452.11 US$2,328,152
2019-12-16 2019-12-13 B Purchase Low David N. Non-Executive Director
21,015 +37.5%
49.47
US$468,043 		21,015 +37.5% 49.47 US$468,043
2019-12-16 2019-12-13 B Purchase Messinger Michael

Chief Financial Officer

Officer
47,421 -37.5%
444.74
US$1,090,974 		47,421 -37.5% 444.74 US$1,090,974
2018-12-06 2018-12-04 S Sale Fosun Industrial Co., Ltd Large shareholder
600,000 -7.1%
2.04
US$1,224,000 		600,000 -7.1% 2.04 US$1,224,000
2018-12-06 2018-12-04 S Sale Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Large shareholder
600,000 -7.1%
2.04
US$1,224,000 		600,000 -7.1% 2.04 US$1,224,000
2017-07-27 2017-07-25 B Purchase BLECH ISAAC Non-Executive Director
16,000 +inf%
1.24
US$19,840 		16,000 +inf% 1.24 US$19,840
2017-07-26 2017-07-25 B Purchase Ricciardi Lisa Non-Executive Director
9,600 +inf%
1.24
US$11,904 		9,600 +inf% 1.24 US$11,904
2017-07-26 2017-07-25 B Purchase Sucoff Cary Non-Executive Director
12,000 +inf%
1.24
US$14,880 		12,000 +inf% 1.24 US$14,880
2017-07-26 2017-07-25 B Purchase Cassino Cara M

Chief Medical Officer

Officer
8,000 +inf%
1.24
US$9,920 		8,000 +inf% 1.24 US$9,920
2017-07-26 2017-07-25 B Purchase Low David N. Non-Executive Director
40,000 +130.9%
1.24
US$49,600 		40,000 +130.9% 1.24 US$49,600
2017-07-26 2017-07-25 B Purchase Bogdanos Natalie

General Counsel

Officer
800 +inf%
1.24
US$992 		800 +inf% 1.24 US$992
2017-07-26 2017-07-25 B Purchase BARER SOL J Non-Executive Director
40,000 +5.2%
1.24
US$49,600 		40,000 +5.2% 1.24 US$49,600
2017-07-26 2017-07-25 B Purchase Messinger Michael

SVP Finance

Officer
800 +6.0%
1.24
US$992 		800 +6.0% 1.24 US$992
2017-07-26 2017-07-25 B Purchase GILMAN STEVEN C

CEO

Executive Director
800 +4.0%
1.24
US$992 		800 +4.0% 1.24 US$992
2017-07-26 2017-07-25 B Purchase Pomerantz Roger Non-Executive Director
800 +inf%
1.24
US$992 		800 +inf% 1.24 US$992
2017-07-26 2017-07-25 B Purchase OTTO MICHAEL J. Non-Executive Director
8,000 +inf%
1.24
US$9,920 		8,000 +inf% 1.24 US$9,920
2017-07-26 2017-07-25 B Purchase Muntner Joshua B

SVP Business Development

Officer
2,000 +inf%
1.24
US$2,480 		2,000 +inf% 1.24 US$2,480
2016-07-27 2016-07-27 B Purchase GILMAN STEVEN C

CEO

Executive Director
20,000 +inf%
2.48
US$49,600 		20,000 +inf% 2.48 US$49,600
Explore more

More insider trading research around ContraFect Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America